Trials / Enrolling By Invitation
Enrolling By InvitationNCT06696040
Immediate Effects on Gait and Spasticity After the Use of Passive Kinesiotherapy Equipment in the Lower Limbs of Neurological Patients
Immediate Effects of Mobilization Performed by Passive Kinesiotherapy Equipment on Lower Limbs on Spasticity and Gait in Neurological Patients
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Fernanda Trubian · Academic / Other
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
Undergo assessment of muscle tone (Ashworth Scale), gait (BAIOBIT) and risk of falling (Timed Up and Go) before using the device; Use the device on the spastic lower limb(s) for 30 minutes; Go through the same assessment carried out previously.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Passive mobilization using a device | The protocol consists of three moments: initial assessment, use of the device, and final assessment. In the initial assessment, participants will be positioned supine on a stretcher, where the muscle tone of the lower limb(s) will be tested using the Modified Ashworth Scale. After the physical test with the Modified Ashworth Scale, the TUG test will be carried out, and, finally, gait assessment with the BAIOBIT Inertial Meter with Accelerometer and Gyroscope. At the end of the initial assessment, the Autofisio500 device will be used. To do this, the participant will be positioned again and comfortably supine on the stretcher, and the previously tested lower limb will be attached to the device for movement, between the knee and ankle joints, for 30 minutes, at maximum speed (11 RPM). For the final assessment, the Modified Ashowrth Scale, TUG and gait assessment with the Inertial Meter with Accelerometer and BAIOBIT Gyroscope will be applied again. |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2028-05-31
- Completion
- 2028-07-31
- First posted
- 2024-11-19
- Last updated
- 2025-03-28
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT06696040. Inclusion in this directory is not an endorsement.